Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Left Main Revascularization: 12 Year Registry in Canada

The current indication for severe left main lesion continues to be coronary artery bypass graft surgery (CABG) but percutaneous coronary intervention (PCI) has come far in this territory thanks to increasing operator experienced and the use of IVUS during procedures.  

tronco de la coronaria izquierda

At present, left main disease have a Class IIa indication in the American guidelines when revascularization will be comparable to surgery, and the European guidelines indicate Class I with low complexity coronary anatomy and Class II with intermediate complexity.

Even though there is good information from important randomized studies with 3 to 5 year followup, it seldom reflects real world data, but we find different registries comparing both strategies. 

This is a retrospective analyzis carried out in Ontario, Canada, between October 2008 and 2020 from patients presenting severe left main lesion receiving revascularization within 90 days.

It included 2526 patients undergoing PCI and 21287 receiving CABG. Over time, the number of PCI patients increased, while CABG decreased. 

Read also: Intracardiac Echocardiography to Guide Watchman Left Atrial Appendix Closure: Safe and Effective?

The populations were different: PCI patients were older, were more often women, had more acute coronary syndrome and more comorbidities. 

Populations were therefore matched with propensity score, leaving 1128 patients in each group. 

There were no differences in hospital or early mortality, (3.7% vs 3.8% y 5.5% vs 3.9%) when comparing PCI against CABG. Neither were there differences in stroke, but there was higher MI rate among PCI patients. (2.7% vs 1.2% P =0.007). 

Read also: FLASH Registry: Mechanical Thrombectomy with FlowTriever.

At 7 year followup, all-cause mortality (53.6% vs 35.2%; HR: 1.63; 95% CI: 1.42-1.87; P < 0.001) and MACCE (66.8% vs 48.6%; HR: 1.77; 95% CI: 1.57-2.00), were higher among PCI patients vs. CABG. Also, PCI saw higher MI rate (10.6% vs. 19.3% 95% CI: 1.77-2.91P>0.0001) and need for repeat revascularization (18.4% vs 6.4% HR: 3.09; 95% CI: 2.31-4.16; P < 0.0001), it was also associated to higher stroke rate (5.3% vs 7.6% HR of 0.61 (95% CI: 0.42-0.89; P < 0.001).

Conclusion

CABG was the most common revascularization procedure in this “real world” registry. Those undergoing PCI were older and had higher risk. After propensity score matching, there were no differences in early mortality but survival and freedom from cardiac and cerebrovascular events were better with CABG. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the editorial board of SOLACI.org.

Original Title: Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada.

Reference: Derrick Y. Tam, et al J Am Coll Cardiol Intv 2023;16:277–288.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...